A trial found six weeks of yoga improved sleep quality and reduced fatigue in people with MS, suggesting its use as a ...

After MS causes symptoms in her hands, columnist Desiree Lama lands on making beaded curtains as a way to improve her fine ...

Experts in multiple sclerosis discuss the potential introduction of a subcutaneous form of ocrelizumab to the market in late 2024 and how they plan to incorporate it into their treatment algorithms.

Therapeutic monoclonal antibodies (mAbs) are potent new tools for a molecular targeted approach to modify the course of multiple sclerosis (MS). Besides natalizumab, which was approved in 2006, three ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic inflammatory disease of the central nervous system caused by the immune system. B ...

MS is an autoimmune disorder in which the immune system attacks myelin, the protective covering of nerve fibres in the brain ...

From baseline to week 12 the adjusted mean difference in Modified Fatigue Impact Scale change was 1.88 and 1.20 for CBT and modafinil, respectively, relative to the combination group. HealthDay News — ...

Immediately after occupational therapy (OT), people with multiple sclerosis may show small improvements in daily functioning and mental health-related quality of life (HR-QoL), but OT may have little ...

The Canadian biotechnology firm Bionxt Solutions has reported encouraging preclinical results for its proprietary drug delivery system. The company’s oral thin film (ODF) formulation of Cladribin, an ...

VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

CombiRx is a randomized clinical trial to determine if the combined use of interferon beta-1a (IFN) and glatiramer acetate (GA) is a measurably better therapy than either agent used individually in ...

The centre in Canterbury wants to bring specialist therapy closer to home for more people in Kent.